標(biāo)題: Titlebook: Anticoagulants, Antiplatelets, and Thrombolytics; Shaker A. Mousa Book 2010Latest edition Springer Science+Business Media, LLC 2010 Anti-X [打印本頁] 作者: vein220 時間: 2025-3-21 19:43
書目名稱Anticoagulants, Antiplatelets, and Thrombolytics影響因子(影響力)
書目名稱Anticoagulants, Antiplatelets, and Thrombolytics影響因子(影響力)學(xué)科排名
書目名稱Anticoagulants, Antiplatelets, and Thrombolytics網(wǎng)絡(luò)公開度
書目名稱Anticoagulants, Antiplatelets, and Thrombolytics網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Anticoagulants, Antiplatelets, and Thrombolytics被引頻次
書目名稱Anticoagulants, Antiplatelets, and Thrombolytics被引頻次學(xué)科排名
書目名稱Anticoagulants, Antiplatelets, and Thrombolytics年度引用
書目名稱Anticoagulants, Antiplatelets, and Thrombolytics年度引用學(xué)科排名
書目名稱Anticoagulants, Antiplatelets, and Thrombolytics讀者反饋
書目名稱Anticoagulants, Antiplatelets, and Thrombolytics讀者反饋學(xué)科排名
作者: HAUNT 時間: 2025-3-21 20:20
Oral Direct Factor Xa Inhibitors, with Special Emphasis on Rivaroxaban,treatment of pulmonary embolism, secondary prevention after acute coronary syndromes, and the prevention of stroke and non-central nervous system embolism in patients with non-valvular atrial fibrillation. The need for new oral anticoagulants, the development and pharmacology of rivaroxaban, results作者: 令人悲傷 時間: 2025-3-22 01:11
Prasugrel: A Novel Platelet ADP P2Y12 Receptor Antagonist,t response, and faster onset of activity compared to clopidogrel. Recent findings from large-scale phase-III testing show prasugrel to be more efficacious in preventing ischemic events in acute coronary syndrome patients undergoing percutaneous coronary intervention (PCI); however, this is achieved 作者: gangrene 時間: 2025-3-22 06:48
Adhesion Molecules: Potential Therapeutic and Diagnostic Implications,d on the key role of CAMs, with special emphasis on integrins in various diseases, as well as the structure–function aspects of cell adhesion and signaling of the different CAMs and ECM are highlighted.作者: Provenance 時間: 2025-3-22 10:16
Diagnosis and Management of Sickle Cell Disorders,xperience. This chapter brings together a detailed etiology, pathophysiology, and clinical presentation of SCD, including the differential diagnoses of pain associated with the disease, with evidence-based recommendations for pain management and the potential impact of low-molecular weight heparin (作者: ARY 時間: 2025-3-22 15:24
1064-3745 getting optimal results.Easy to use and up to date, Anticoagulants, Antiplatelets, and Thrombolytics, Second Edition is an ideal guide for researchers aiming for the future of this vital field, focusing on the978-1-4939-6097-2978-1-60761-803-4Series ISSN 1064-3745 Series E-ISSN 1940-6029 作者: Stress-Fracture 時間: 2025-3-22 20:58 作者: 怕失去錢 時間: 2025-3-23 00:24
https://doi.org/10.1007/978-3-322-88746-7treatment of pulmonary embolism, secondary prevention after acute coronary syndromes, and the prevention of stroke and non-central nervous system embolism in patients with non-valvular atrial fibrillation. The need for new oral anticoagulants, the development and pharmacology of rivaroxaban, results作者: 詳細目錄 時間: 2025-3-23 03:54
https://doi.org/10.1007/978-3-658-28020-8t response, and faster onset of activity compared to clopidogrel. Recent findings from large-scale phase-III testing show prasugrel to be more efficacious in preventing ischemic events in acute coronary syndrome patients undergoing percutaneous coronary intervention (PCI); however, this is achieved 作者: Adenoma 時間: 2025-3-23 07:40
,Vorstudie für Studien 2 und 3,d on the key role of CAMs, with special emphasis on integrins in various diseases, as well as the structure–function aspects of cell adhesion and signaling of the different CAMs and ECM are highlighted.作者: EXULT 時間: 2025-3-23 10:10
Jochen Mayerl,Thomas Krause,Marius Wuketichxperience. This chapter brings together a detailed etiology, pathophysiology, and clinical presentation of SCD, including the differential diagnoses of pain associated with the disease, with evidence-based recommendations for pain management and the potential impact of low-molecular weight heparin (作者: 來這真柔軟 時間: 2025-3-23 17:17 作者: Psychogenic 時間: 2025-3-23 19:37 作者: 來這真柔軟 時間: 2025-3-24 00:25
Kultur im Kontext agiler Teamarbeit, also play a pivotal role in the pathogenesis of arterial thrombotic disorders, including unstable angina (UA), myocardial infarction (MI), and stroke. The underlying pathophysiological mechanism of these processes has been recognized as the disruption or erosion of a vulnerable atherosclerotic plaq作者: obeisance 時間: 2025-3-24 03:48
,Praktische Anwendung der R?ntgenstrahlen,e selection of new agents for clinical evaluation, and have informed dosing and safety information for clinical trials. These models also provide valuable information about the mechanisms of action/interaction of new antithrombotic agents. Small and large animal models of thrombosis and their role i作者: 施魔法 時間: 2025-3-24 09:28
,Praktische Anwendung der R?ntgenstrahlen, focused on the plasma anti-Xa and anti-IIa pharmacodynamics of different LMWHs. Other important pharmacodynamic parameters for heparin and LMWH, including effects on vascular tissue factor pathway inhibitor (TFPI) release, inhibition of inflammation through NFκB, inhibition of key matrix-degrading 作者: Fracture 時間: 2025-3-24 13:21 作者: Inferior 時間: 2025-3-24 18:13
https://doi.org/10.1007/978-3-658-07196-7cesses, including venous thromboembolism (VTE) and inflammatory diseases. Major advances in the development of oral anticoagulants have resulted in considerable progress toward the goal of safe and effective oral anticoagulants that do not require frequent monitoring or dose adjustment and have mini作者: sparse 時間: 2025-3-24 22:48
https://doi.org/10.1007/978-3-322-88746-7osis. To date, oral anticoagulants have been limited largely to vitamin K antagonists. Despite their remarkable benefits, vitamin K antagonists are limited by their narrow therapeutic window, the existence of multiple food and drug interactions, and the need for frequent monitoring and dose-adjustme作者: ALLAY 時間: 2025-3-25 00:51 作者: 注意力集中 時間: 2025-3-25 06:00
https://doi.org/10.1007/978-3-658-28020-8nt. These ADP P2Y. antagonists have advantages over clopidogrel ranging from faster onset to greater and less variable inhibition of platelet function. Novel ADP P2Y. antagonists are under investigation to determine whether their use can result in improved antiplatelet activity, faster onset of acti作者: notice 時間: 2025-3-25 09:49 作者: 一瞥 時間: 2025-3-25 14:38
https://doi.org/10.1007/978-3-658-36370-3activation plays an important role in the biology of malignant tumors, including the process of blood-borne metastasis. For many years our laboratory has used experimental models of lung metastasis to study the events that follow the introduction of procoagulant-bearing tumor cells into circulating 作者: 血統(tǒng) 時間: 2025-3-25 16:57 作者: Ataxia 時間: 2025-3-25 23:13
https://doi.org/10.1007/978-3-658-21999-4o an individual’s genetic makeup in order to improve the benefit-to-risk ratio. Significant findings have been documented showing the effect of certain genetic variations (e.g., in . and .1) on the dose response to warfarin. Pharmacogenomic and genetic information is crucial to improving the efficac作者: 險代理人 時間: 2025-3-26 03:02
Jochen Mayerl,Thomas Krause,Marius Wuketichn the β-globin chain, causing a spectrum of clinical manifestations in addition to hemolysis and anemia. Acute painful crisis is a common sequela that can cause significant morbidity and negatively impact the patient’s quality of life. Remarkable improvements in our understanding of the pathogenesis作者: Juvenile 時間: 2025-3-26 04:50 作者: 樹膠 時間: 2025-3-26 10:05
Methods in Molecular Biologyhttp://image.papertrans.cn/a/image/158524.jpg作者: deviate 時間: 2025-3-26 16:29
https://doi.org/10.1007/978-1-60761-803-4Anti-Xa agents; Antithrombotic drugs; Oral anticoagulants; Pharmaceutical development; Thromboembolic di作者: 休息 時間: 2025-3-26 17:58
978-1-4939-6097-2Springer Science+Business Media, LLC 2010作者: Muffle 時間: 2025-3-26 21:03 作者: 吝嗇性 時間: 2025-3-27 04:18
Antithrombotic Effects of Naturally Derived Products on Coagulation and Platelet Function,antagonist activity), alfalfa (high-vitamin K content), and coenzyme Q10 (vitamin K-like activity), may affect blood clotting, which is dependent on vitamin K. Studies are needed to understand the role of various dietary supplements in thrombosis and their interactions with standard anticoagulants and antiplatelet drugs.作者: Antigen 時間: 2025-3-27 05:50
1064-3745 tips on troubleshooting and avoiding common pitfalls.IncludDuring the past decade, remarkable progress has been made in the development of newer drugs to prevent and treat thromboembolic disorders, such as oral direct anti-Xa and anti-IIa antagonists, as well as oral antiplatelet ADP antagonists wi作者: HUSH 時間: 2025-3-27 13:18
https://doi.org/10.1007/978-3-658-07196-7mbosis. Although the diagnosis and treatment of HIT can be difficult and complex, it is critical that patients with HIT be identified as soon as possible to initiate early treatment to avoid thrombosis.作者: macabre 時間: 2025-3-27 16:28
https://doi.org/10.1007/978-3-658-21999-4n genetic variations (e.g., in . and .1) on the dose response to warfarin. Pharmacogenomic and genetic information is crucial to improving the efficacy and safety of pharmacotherapy and for the optimal management of thromboembolic disorders.作者: 貝雷帽 時間: 2025-3-27 21:25 作者: 懶鬼才會衰弱 時間: 2025-3-27 23:35
Pharmacogenomics in Thrombosis,n genetic variations (e.g., in . and .1) on the dose response to warfarin. Pharmacogenomic and genetic information is crucial to improving the efficacy and safety of pharmacotherapy and for the optimal management of thromboembolic disorders.作者: ANA 時間: 2025-3-28 05:15 作者: 打包 時間: 2025-3-28 10:14 作者: 一致性 時間: 2025-3-28 14:11
https://doi.org/10.1007/978-3-658-36370-3dent models of experimental metastasis. In addition, it summarizes our experience with these models, which collectively suggests that intravascular coagulation and platelet activation are a necessary prelude to lung tumor formation and that interruption of coagulation pathways or platelet aggregation may be an effective anti-metastatic strategy.作者: headway 時間: 2025-3-28 17:29 作者: sinoatrial-node 時間: 2025-3-28 20:05 作者: 充氣女 時間: 2025-3-29 00:19 作者: 調(diào)整 時間: 2025-3-29 05:29 作者: 紋章 時間: 2025-3-29 08:52
Heparin and Low-Molecular Weight Heparins in Thrombosis and Beyond,enzymes, selectin modulation, inhibition of platelet–cancer cell interactions, and inflammatory cell adhesion, help explain the diverse clinical impact of this class of agents in thrombosis and beyond.作者: synovium 時間: 2025-3-29 14:14 作者: 凹處 時間: 2025-3-29 16:43
,Praktische Anwendung der R?ntgenstrahlen,enzymes, selectin modulation, inhibition of platelet–cancer cell interactions, and inflammatory cell adhesion, help explain the diverse clinical impact of this class of agents in thrombosis and beyond.作者: 歡樂中國 時間: 2025-3-29 21:32
Book 2010Latest editionl direct anti-Xa and anti-IIa antagonists, as well as oral antiplatelet ADP antagonists with rapid onset and offset. In addition, there has been concentrated effort aimed at identifying novel uses of traditional antithrombotic drugs, such as aspirin, heparin, and oral anticoagulants, as well as comb作者: 抑制 時間: 2025-3-30 02:54
In Vitro Methods of Evaluating Antithrombotics and Thrombolytics, also play a pivotal role in the pathogenesis of arterial thrombotic disorders, including unstable angina (UA), myocardial infarction (MI), and stroke. The underlying pathophysiological mechanism of these processes has been recognized as the disruption or erosion of a vulnerable atherosclerotic plaq作者: 欺騙世家 時間: 2025-3-30 04:14
In Vivo Models for the Evaluation of Antithrombotics and Thrombolytics,e selection of new agents for clinical evaluation, and have informed dosing and safety information for clinical trials. These models also provide valuable information about the mechanisms of action/interaction of new antithrombotic agents. Small and large animal models of thrombosis and their role i作者: considerable 時間: 2025-3-30 11:38
Heparin and Low-Molecular Weight Heparins in Thrombosis and Beyond, focused on the plasma anti-Xa and anti-IIa pharmacodynamics of different LMWHs. Other important pharmacodynamic parameters for heparin and LMWH, including effects on vascular tissue factor pathway inhibitor (TFPI) release, inhibition of inflammation through NFκB, inhibition of key matrix-degrading 作者: 不理會 時間: 2025-3-30 12:56 作者: Hormones 時間: 2025-3-30 16:32
Novel Anticoagulant Therapy: Principle and Practice,cesses, including venous thromboembolism (VTE) and inflammatory diseases. Major advances in the development of oral anticoagulants have resulted in considerable progress toward the goal of safe and effective oral anticoagulants that do not require frequent monitoring or dose adjustment and have mini作者: abduction 時間: 2025-3-30 22:45 作者: CRAB 時間: 2025-3-31 03:50 作者: 姑姑在炫耀 時間: 2025-3-31 08:45
Prasugrel: A Novel Platelet ADP P2Y12 Receptor Antagonist,nt. These ADP P2Y. antagonists have advantages over clopidogrel ranging from faster onset to greater and less variable inhibition of platelet function. Novel ADP P2Y. antagonists are under investigation to determine whether their use can result in improved antiplatelet activity, faster onset of acti作者: Euthyroid 時間: 2025-3-31 12:34
